source
- CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreakThe Coalition for Epidemic Preparedness Innovations has committed up to $16.5 million to push Minapharm’s Bundibugyo vaccine candidate into the clinic, furthering its response to the Ebola outbreak.Fierce Biotech · 8h ago↗ source
- Osivax bags flu vaccine rights to pursue combination shot visionOsivax has licensed an influenza vaccine from GC Biopharma, positioning the biotech to build on early evidence that its midphase candidate complements traditional flu shots.Fierce Biotech · 9h ago↗ source
- FDA grants three-month extension for Capricor's Duchenne muscular dystrophy cell therapy reviewThe FDA has granted a three‑month extension to Capricor Therapeutics' review of its cell therapy for Duchenne muscular dystrophy after the original PDUFA date passed. The decision follows a content…